Loading clinical trials...
Loading clinical trials...
Low Molecular Weight Heparin Versus Aspirin for Venous Thromboembolism Prophylaxis in Orthopaedic Oncology
Conditions
Interventions
Aspirin 325mg
Enoxaparin 40Mg/0.4mL Prefilled Syringe
Locations
10
United States
University of California Los Angeles Health
Los Angeles, California, United States
Moffitt Cancer Center
Tampa, Florida, United States
Louisiana State University Health
New Orleans, Louisiana, United States
Johns Hopkins University
Baltimore, Maryland, United States
Santiago Lozano-Calderon
Boston, Massachusetts, United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
Start Date
February 16, 2018
Primary Completion Date
December 31, 2027
Completion Date
July 1, 2028
Last Updated
October 3, 2025
NCT06926283
NCT07548177
NCT03050268
NCT06422806
NCT07467772
NCT05969860
Lead Sponsor
Massachusetts General Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions